InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank20
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-9.23M
Near historical average
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-8.93M
Historical baseline
PeriodValueYoY Change
TTM$-9.23M-16.5%
2025$-7.92M+2.7%
2024$-8.13M+2.9%
2023$-8.38M+39.2%
2022$-13.79M-13.3%
2021$-12.17M-33.0%
2020$-9.15M+11.7%
2019$-10.36M-52.8%
2018$-6.78M-97.1%
2017$-3.44M-